Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Trouw

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy ControlsH Koppejan, L A Trouw, J Sokolove, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 31, 2018
Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et alV F A M Derksen, L A Trouw, T W J Huizinga, et al.
Annals of the Rheumatic Diseases|April 28, 2016
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factorS Ajeganova, H W van Steenbergen, M K Verheul, et al.
Annals of the Rheumatic Diseases|March 12, 2017
Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies presentV F A M Derksen, S Ajeganova, L A Trouw, et al.
Annals of the Rheumatic Diseases|March 7, 2013
Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritisParawee Suwannalai, Karin Britsemmer, Rachel Knevel, et al.
RMD Open|December 20, 2023
Type 17-specific immune pathways are active in early spondyloarthritisCatherine D Hughes, Sarah E Ryan, Kathryn J A Steel, et al.
Rheumatology (Oxford, England)|October 14, 2004
A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosusM A Seelen, E A van der Bijl, L A Trouw, et al.
Osteoarthritis and Cartilage|October 22, 2019
Complement component C1q is produced by isolated articular chondrocytesR Lubbers, R A van Schaarenburg, J C Kwekkeboom, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigensP Suwannalai, H U Scherer, D van der Woude, et al.
Arthritis and Rheumatism|December 2, 2011
Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritisP Suwannalai, L A van de Stadt, H Radner, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy ControlsH Koppejan, L A Trouw, J Sokolove, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 31, 2018
Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et alV F A M Derksen, L A Trouw, T W J Huizinga, et al.
Annals of the Rheumatic Diseases|April 28, 2016
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factorS Ajeganova, H W van Steenbergen, M K Verheul, et al.
Annals of the Rheumatic Diseases|March 12, 2017
Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies presentV F A M Derksen, S Ajeganova, L A Trouw, et al.
Annals of the Rheumatic Diseases|March 7, 2013
Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritisParawee Suwannalai, Karin Britsemmer, Rachel Knevel, et al.
RMD Open|December 20, 2023
Type 17-specific immune pathways are active in early spondyloarthritisCatherine D Hughes, Sarah E Ryan, Kathryn J A Steel, et al.
Rheumatology (Oxford, England)|October 14, 2004
A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosusM A Seelen, E A van der Bijl, L A Trouw, et al.
Osteoarthritis and Cartilage|October 22, 2019
Complement component C1q is produced by isolated articular chondrocytesR Lubbers, R A van Schaarenburg, J C Kwekkeboom, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigensP Suwannalai, H U Scherer, D van der Woude, et al.
Arthritis and Rheumatism|December 2, 2011
Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritisP Suwannalai, L A van de Stadt, H Radner, et al.
Pageof 5